Medtronic’s Enlite Sensor Provides Improved Comfort for Continuous Glucose Monitoring Patients
by on Apr 12, 2011 • 1:09 pm
Medtronic has announced CE marking and the pending launch of its new Enlite sensor for use with the company’s continuous glucose monitoring (CGM) systems. The Enlite has demonstrated better accuracy than Medtronic’s previous CGM sensors, and provides greater patient comfort due to its smaller profile. CGM has proven more effective than manual finger-prick testing at enabling patients to manage their blood sugar, and Medtronic hopes that the Enlite’s improved comfort will lead to greater adoption of CGM. The new sensor is designed for use with Medtronic’s MiniMed Paradigm REAL-Time System, MiniMed Paradigm Veo System, Guardian REAL-Time Continuous Glucose Monitoring System, and the iPro2.
From the press release:
Significant design improvements make Enlite Sensor more comfortable and easier to use than the previous sensor. In a clinical study of Enlite Sensor, 85% of patients agreed that sensor insertion was pain free and 86% agreed that the Enlite insertion device was easy to use. The Enlite Sensor is a significantly smaller sensor compared to Medtronic’s previous product – 69% smaller in sensor size by volume, 38% shorter in length. Adding to patient convenience, the Enlite Sensor can be worn on the abdomen and buttocks and used for up to six days.
Press release: Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control…
Johns Hopkins University has chosen Unbound Medicine as the official electronic publisher of its Antibiotic (ABX), Diabetes, and HIV POC-IT Guides. The guides provide evidenced-based information that is regularly updated so they stay on top of the latest clinical knowledge.
The popular networking site PatientsLikeMe is finally opening its doors to people with any medical condition. Until now only patients with 22 chronic conditions were able to participate in the site’s communities, setting the stage for a wider roll-out. PatientsLikeMe also created an interesting 
MedCity News is reporting that SPR Therapeutics of Cleveland, Ohio is close to receiving FDA regulatory approval for its SMARTPATCH Peripheral Nerve Stimulation System aimed at treating shoulder pain in patients post stroke. The device utilizes percutaneous leads to stimulate muscle activity and in turn reduce pain.
alternative to manual closure, as a speedy and efficient way that will ultimately save time and money for surgeons and hospitals, by lowering intraoperative costs.
Room4, a company out of East Sussex, UK, has released its Interpath pathology slide viewing app for the iPad. Previously available only on the iPhone, the larger iPad screen makes browsing images much faster and more productive. The app relies on a slide scanner connected to a server from which relevant sections are transferred to the mobile device.
